NCT04375514 - Study of ARO-ENaC in Healthy Volunteers and in Patients With Cystic Fibrosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 10, 2020

Primary Completion Date

September 3, 2021

Study Completion Date

September 3, 2021

Conditions

Cystic Fibrosis, Pulmonary

Interventions

DRUG

ARO-ENaC

single or multiple doses of ARO-ENaC by inhalation of nebulized solution

DRUG

Placebo

calculated volume to match active treatment by inhalation of nebulized solution

Trial Locations (7)

Research Site, Grafton

Research Site, Hamilton

Research Site, Chermside

Research Site, South Brisbane

Research Site, Nedlands

Research Site, Christchurch

Research Site, Dunedin